Table 3.

Consensus criteria for relapse definition in pediatric ALL: BM relapse (MRD available)

BM 1BM 2*
MRDOthersMRD
≥25% Not necessary to define relapse Not necessary to define relapse 
Five to <25% One other test with ≥1% blasts Not necessary to define relapse 
Five to <25% None Two tests with with ≥1% blasts 
One to <5% Two other tests with with ≥1% blasts Not necessary to define relapse 
One to <5% Zero or 1 other test with ≥1% blasts Two tests with ≥1% blasts 
BM 1BM 2*
MRDOthersMRD
≥25% Not necessary to define relapse Not necessary to define relapse 
Five to <25% One other test with ≥1% blasts Not necessary to define relapse 
Five to <25% None Two tests with with ≥1% blasts 
One to <5% Two other tests with with ≥1% blasts Not necessary to define relapse 
One to <5% Zero or 1 other test with ≥1% blasts Two tests with ≥1% blasts 
*

Second bone marrow evaluation ≥1 wk later.

FCM/PCR/NGS-based MRD or FISH/karyotype/PCR demonstrating leukemia-specific marker or M2/M3 morphology.

or Create an Account

Close Modal
Close Modal